Inventor
KUMON HIROMI
JP15 patents
⚠️ This page may combine multiple inventors who share the name “KUMON HIROMI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KUMON HIROMI
8 patentsUS8658611B2Feb 25, 2014
Apoptosis-inducing agent for prostate cancer cells
KUMON HIROMI7 citations80
US9222107B2Dec 29, 2015
REIC-expressing adenovirus vector
KUMON HIROMI4 citations67
US9493776B2Nov 15, 2016
System for increasing gene expression and vector comprising the system
KUMON HIROMI2 citations60
US8658612B2Feb 25, 2014
Therapeutic agent for malignant mesothelioma and immunostimulant
KUMON HIROMI3 citations59
US8614093B2Dec 24, 2013
Pharmaceutical composition for treating or preventing cancer by inducing dendritic cell-like differentiation from monocytes to improve anticancer immune activity
KUMON HIROMI2 citations59
US9475865B2Oct 25, 2016
Direct administration of REIC/Dkk-3 to mesothelioma
KUMON HIROMI2 citations58
US8618273B2Dec 31, 2013
Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the same
KUMON HIROMI4 citations58
US8946173B2Feb 3, 2015
Cancer cell death inducing agent having effects of potentiating anticancer drug against anticancer-drug-resistant cancer
KUMON HIROMI3 citations56
NAT UNIV CORPORATION OKAYAMA UNIV
2 patentsUS10071126B2Sep 11, 2018
Conditionally replicating adenovirus to express REIC gene
NAT UNIV CORPORATION OKAYAMA UNIV9 citations82
US10782296B2Sep 22, 2020
Antibody that specifically recognizes and binds to REIC/Dkk-3 protein having active structure and monitoring of cancer treatment using such anti-REIC/Dkk-3 antibody
NAT UNIV CORPORATION OKAYAMA UNIV0 citations45